- Home
- XPON vs KTTA Comparison
XPON vs KTTA Comparison
Compare XPON & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPON
- KTTA
- Stock Information
- Founded
- XPON 2016
- KTTA 2020
- Country
- XPON United States
- KTTA United States
- Employees
- XPON N/A
- KTTA N/A
- Industry
- XPON Electronic Components
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- XPON Technology
- KTTA Health Care
- Exchange
- XPON Nasdaq
- KTTA Nasdaq
- Market Cap
- XPON 6.2M
- KTTA 5.7M
- IPO Year
- XPON 2022
- KTTA 2021
- Fundamental
- Price
- XPON $1.21
- KTTA $0.71
- Analyst Decision
- XPON
- KTTA
- Analyst Count
- XPON 0
- KTTA 0
- Target Price
- XPON N/A
- KTTA N/A
- AVG Volume (30 Days)
- XPON 2.0M
- KTTA 91.7K
- Earning Date
- XPON 11-13-2025
- KTTA 11-13-2025
- Dividend Yield
- XPON N/A
- KTTA N/A
- EPS Growth
- XPON N/A
- KTTA N/A
- EPS
- XPON N/A
- KTTA N/A
- Revenue
- XPON $9,417,947.00
- KTTA N/A
- Revenue This Year
- XPON $61.26
- KTTA N/A
- Revenue Next Year
- XPON N/A
- KTTA N/A
- P/E Ratio
- XPON N/A
- KTTA N/A
- Revenue Growth
- XPON 109.37
- KTTA N/A
- 52 Week Low
- XPON $0.60
- KTTA $0.65
- 52 Week High
- XPON $5.50
- KTTA $3.85
- Technical
- Relative Strength Index (RSI)
- XPON 40.65
- KTTA 46.01
- Support Level
- XPON $1.11
- KTTA $0.69
- Resistance Level
- XPON $1.32
- KTTA $0.75
- Average True Range (ATR)
- XPON 0.11
- KTTA 0.06
- MACD
- XPON -0.00
- KTTA -0.01
- Stochastic Oscillator
- XPON 18.32
- KTTA 33.98
About XPON Expion360 Inc.
Expion360 Inc is focused on the design, assembly, manufacturing, and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles (RV's) and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).